Not Yet Recruiting
Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant
NCT06768697
- Conditions
- COVID - 19, COVID-19, Coronaviridae Infections, +10 more
- Locations
-
- Shanghai Public Health Clinical Center,Fudan University Shanghai, Jinshan District, China